Pharmaceuticals Brazil

Brazil Whole Genome Sequencing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Brazil Whole Genome Sequencing Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $75.2 Mn Placeholder estimate
Estimate 2025 $89.7 Mn 2.6% of the global market
Projected 2034 $438.9 Mn 389.5% Adds $349.3 Mn over 9 forecast years
CAGR 2025–2034 19.3% Faster than 84% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Brazil is 2.58% of the global market.
  • In Latin America, the largest is Brazil (this report) at $89.7 Mn.
  • Fastest growing: Brazil (this report) at 19.3% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$349.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Whole Genome Sequencing Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $75.2 Mn — —
2025 (base) $89.7 Mn +$14.5 Mn —
2026 (forecast) $107.0 Mn +$17.3 Mn +19.3%
2027 (forecast) $127.6 Mn +$20.6 Mn +42.3%
2028 (forecast) $152.2 Mn +$24.6 Mn +69.8%
2029 (forecast) $181.6 Mn +$29.4 Mn +102.6%
2030 (forecast) $216.7 Mn +$35.1 Mn +141.7%
2031 (forecast) $258.5 Mn +$41.8 Mn +188.3%
2032 (forecast) $308.4 Mn +$49.9 Mn +243.9%
2033 (forecast) $367.9 Mn +$59.5 Mn +310.3%
2034 (forecast) $438.9 Mn +$71.0 Mn +389.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.48 Bn
  2. North America $1.76 Bn
  3. US $1.36 Bn
  4. APAC $684.4 Mn
  5. Europe $610.8 Mn
  6. Canada $299.6 Mn
  7. China $251.0 Mn
  8. Japan $238.8 Mn
  9. Germany $138.0 Mn
  10. Latin America $138.5 Mn
  11. Middle East $132.8 Mn
  12. Italy $92.0 Mn
  13. Brazil (this report) $89.7 Mn
  14. UK $83.4 Mn
  15. France $80.1 Mn
  16. Ecuador $67.2 Mn
  17. India $68.6 Mn
  18. Spain $63.3 Mn
  19. Saudi Arabia $60.8 Mn
  20. Mexico $50.7 Mn
  21. Africa $49.8 Mn
  22. New Zealand $39.2 Mn
  23. Russia $38.5 Mn
  24. Australia $38.9 Mn
  25. South Africa $24.6 Mn
  26. UAE $15.7 Mn
  27. Egypt $11.3 Mn
  28. Philippines $7.9 Mn
  29. Hong Kong $6.2 Mn
  30. Malaysia $5.5 Mn
  31. Thailand $4.5 Mn
  32. Singapore $4.1 Mn
  33. Kenya $2.1 Mn

Report snapshot

Brazil Whole Genome Sequencing Market Analysis at a glance
Market size, 2025$89.7 Mn placeholder estimate
Forecast, 2034$438.9 Mn placeholder estimate
Growth (CAGR), 2025–203419.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersIllumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies, Element Biosciences (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil Whole Genome Sequencing Market Analysis Executive Summary

Whole genome sequencing reads a person's entire DNA code, used for rare disease diagnosis, cancer, research and population health.

Key segments of the whole Genome Sequencing market include product (Instruments, Consumables and Services) and application (Rare Disease Diagnosis, Oncology and Population Genomics).

Bar chart: Brazil Whole Genome Sequencing market size, 2024–2034, placeholder estimates. $75.2 Mn in 2024, $89.7 Mn in 2025 and $438.9 Mn in 2034, 19.3% CAGR.
Brazil Whole Genome Sequencing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil Whole Genome Sequencing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the whole Genome Sequencing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the whole Genome Sequencing market.

Competitive Landscape for Whole Genome Sequencing Market in Brazil

The whole Genome Sequencing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Whole Genome Sequencing Market in Brazil

Whole Genome Sequencing in Brazil: rules and payment

Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for whole Genome Sequencing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Whole Genome Sequencing right now, from free public sources.

Latest research 29,479 papers since 2021 (worldwide)

  1. Genomic profiling of maternal Streptococcus agalactiae reveals prophage-associated resistance and comparative characterization of anovaginal and respiratory isolates. Microbial pathogenesis, 2026
  2. Prevalence of new and repurposed drug resistance and associated genetic variants among rifampicin-resistant Mycobacterium tuberculosis in Shenzhen, China: a population-based study. International journal of antimicrobial agents, 2026
  3. Genomic Insights into Early Catheter-Associated UTIs in a Clinical Setting: High-Risk Clones, Hidden Diversity and Limited Catheter-Urine Genomic Divergence. The Journal of hospital infection, 2026
  4. Genomic and phenotypic characterization of four foodborne Vibrio harveyi: Insights into antimicrobial resistance, secretion systems, and ecological fitness. International journal of food microbiology, 2026
  5. The hidden burden of structural variants in neurodegenerative and neuromuscular disorders. Scientific reports, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Whole Genome Sequencing in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Whole Genome Sequencing market in Brazil?
Placeholder estimate: about $89.7 Mn in 2025, rising to about $438.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Whole Genome Sequencing market in Brazil growing?
Placeholder estimate: about 19.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Whole Genome Sequencing market report cover?
The report splits the market by product (Instruments, Consumables, Services, Data Analysis), application (Rare Disease Diagnosis, Oncology, Population Genomics, Research) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Whole Genome Sequencing market?
Key players include Illumina, Inc., MGI Tech, Pacific Biosciences, Oxford Nanopore Technologies and Element Biosciences.
What is driving the Whole Genome Sequencing market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the whole Genome Sequencing market.
Who regulates Whole Genome Sequencing in Brazil?
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How much research is published on Whole Genome Sequencing?
PubMed lists 29,479 papers on Whole Genome Sequencing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Whole Genome Sequencing in Brazil? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Brazil

See all
Same topic, other categories

Related on genomics

See the topic